By incorporation of the azobenzene device, a photoswitchable Edition of propofol (AP2) was developed in 2012 that allows for optical Charge of GABAA receptors with gentle.[76] In 2013, a propofol binding site on mammalian GABAA receptors has long been identified by photolabeling employing a diazirine spinoff.The above mentioned graph shows the vari